Modulation of murine in vitro immune response by verapamil (V)

A B Singh1, K Hiehle, P Casale

  • 1Division of Nephrology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903-0019.

Immunopharmacology
|November 1, 1990
PubMed

Insights

Calcium influx is crucial for activating cytotoxic T lymphocytes (CTL) and B cells, but not suppressor cells. Verapamil, a calcium channel blocker, selectively inhibits CTL and B cell induction, highlighting differential calcium dependency in lymphocyte activation.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Lymphocyte activation requires specific signals, with transcellular calcium influx being critical in some cases.
  • The role of calcium in activating all lymphocyte subsets is not fully understood.

Purpose of the Study:

  • To investigate the effect of the calcium channel blocker verapamil on the induction of murine cytotoxic T lymphocytes (CTL), suppressor cells, T helper cells, and B cells.
  • To determine the selective role of calcium in lymphocyte activation.

Main Methods:

  • Treatment of murine lymphocytes with verapamil (V).
  • Assessment of the induction of CTL, suppressor cells, T helper cells, and B cells.
  • Evaluation of verapamil's synergy with cyclosporin A (CsA) and reversal by exogenous helper factors.

Main Results:

  • Verapamil inhibited the induction of cytotoxic effector cells, acting on the afferent immune response limb.
  • Verapamil synergized with CsA and its effects were reversible with helper factors.
  • Verapamil inhibited B cell proliferation without T cell help but did not inhibit B cell activation or suppressor cell induction.

Conclusions:

  • Calcium plays a selective role in lymphocyte activation, being essential for CTL and B cell induction but not suppressor cell induction.
  • Verapamil's selective suppression provides insights into the differential activation requirements of various lymphocyte subsets.

Related Concept Videos